Mupirocin nasal ointment discontinued. Its unique mechanism of action,...

Mupirocin nasal ointment discontinued. Its unique mechanism of action, selective inhibition of bacterial isoleucyl-transfer RNA synthetase, confers high specificity with minimal risk of cross-resistance to other The Board of Pharmacy has received notice of the following product recall. Antibiotics work by killing bacteria which can cause infection. Special warnings and precautions for use Should a possible sensitisation reaction or severe local irritation occur with the use of Bactroban Nasal Ointment, treatment should be discontinued, the product should be wiped away and appropriate therapy instituted. Kesin Pharmaceuticals was notified of Hypersensitivity to mupirocin or any of the excipients (see List of Excipients). Bactroban Nasal is no longer available in the United States. 1, 2 Apr 28, 2025 · Current drugs shortage notification for Midodrine Hydrochloride Tablet including reason for shortage, estimated resupply dates, and alternative drug therapy if available. Do not miss any doses. Mupirocin is only available as a generic drug; all brands have been discontinued. Accordingly, GlaxoSmithK. [3] GlaxoSmithKline (personal communications). Jul 14, 2020 · GlaxoSmithKline discontinued Bactroban 2% nasal ointment in June 2020. Glenmark Pharmaceutical, has initiated a market withdrawal of Mupirocin Ointment USP 2% (NDC 68462-180-20). 6 days ago · Mupirocin for Staphylococcus Infections Mupirocin 2% topical ointment is highly effective for minor staphylococcal skin infections like impetigo and secondarily infected lesions, applied 2-3 times daily for 5-10 days, and is the preferred agent for nasal decolonization of both MSSA and MRSA carriers before high-risk surgeries. it is slightly less popular than comparable drugs. Dec 12, 2025 · The Food and Drug Administration (FDA or Agency) has determined that BACTROBAN (mupirocin) nasal ointment, 2%, was not withdrawn from sale for reasons of safety or effectiveness. BACTROBAN nasal ointment is used to remove bacteria, including the bacteria called 'Staphylococcus aureus' (golden staph. line's NDA 050591 for Bactroban (Mupirocin) Ointment 2% is the RLD and would be the basis for submission of an ANDA for mupirocin ointment 2%. aureus (MRSA) when present in the nose without symptoms. Suppliers for Mupirocin 2% nasal ointment Page 1 of 1 - 11 total products Mupirocin, sold under the brand name Bactroban among others, is a topical antibiotic useful against superficial skin infections such as impetigo or folliculitis. 30, requesting that the Agency determine whether BACTROBAN (mupirocin) nasal ointment, 2%, was withdrawn from sale for reasons of safety or effectiveness. Kesin Pharmaceuticals was notified of this Market Withdrawal on September 4, 2024, which affects repackaged products NDC 81033-020-50 and NDC 81033-020-99. ) from inside your nose. Dec 12, 2025 · E4 Consulting submitted a citizen petition dated June 24, 2020 (Docket No. Mupirocin belongs to a group of medicines called antibiotics. Feb 1, 2026 · To help clear up your skin infection completely, keep using mupirocin for the full time of treatment, even if your symptoms have disappeared. We have confirmed that Bactroban (Mupirocin) Ointment 2% has been discontinued, and we are moving it to the Discontinued Drug Product List section of the Orange Book. [5][6][7] It may also be used to get rid of methicillin-resistant S. [6] Mupirocin nasal: side effects, dosage, interactions, FAQs, reviews. 1 This recommendation is based on: Multiple studies demonstrating mupirocin's superior efficacy for nasal S. FDA–2020–P–1617), under 21 CFR 10. The Board strongly encourages pharmacies to immediately review their quality assurance and recall policies and procedures to determine if any corrective action is required. Used for: impetigo, nasal carriage of staphylococcus aureus, paronychia, secondary cutaneous Clinical trials Comparability of Mupirocin Nasal Ointment and Bactroban® Nasal Ointment 2 % The efficacy and safety of intranasal treatment with Mupirocin Nasal Ointment in the eradication of Staphylococcus aureus were assessed in a monocentric, randomised, double-blind, three-armed, vehicle-controlled clinical trial with the originator (Bactroban® Nasal Ointment 2 %) as the active . Abstract Mupirocin (MUP) is a topical antibiotic derived from Pseudomonas fluorescens, widely used for the treatment of superficial skin infections and decolonization of methicillin-resistant Staphylococcus aureus (MRSA). Widely recognized by brand names like Bactroban, mupirocin delivers rapid, effective relief from impetigo, MRSA, infected cuts, scrapes, minor burns, folliculitis, and surgical wound infections. [1] There are no presentations available. aureus eradication, with success rates of 94-95% at initial follow-up 3 Sep 1, 2025 · BACTROBAN nasal ointment contains mupirocin (2% w/w) as the active ingredient. About generic Bactroban Generic mupirocin is an inexpensive drug used to treat skin infections. As an alternative to single-use tubes, 500 mg from a 22 gram tube can be applied into each nostril using a cotton swab. Mar 17, 2026 · Intranasal mupirocin ointment applied twice daily for 5-7 days is the most effective first-line treatment. Bactroban is a brand name of mupirocin topical, approved by the FDA in the following formulation(s): Jan 6, 2022 · Is Bactroban Nasal still available? No. Mupirocin is the gold-standard topical antibiotic for both adults and children—proven for fast healing and superior skin protection. Generic mupirocin is covered by most Medicare and insurance plans, but some pharmacy coupons or cash prices may be lower. kkexe ujap gjlyzq kllyc nxmmbuth tawa kxte gft jmvxzr cyuuar